Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
If I were a health care provider and someone came into my hospital, I would have the expertise to understand that PCR testing is a diagnostic tool, only one of several considerations in determining treatment.
And I would certainly know better than to assess diagnostic tools based on what people say on facebook.
--------------------------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------------------------
EUA withdrawal for CDC COVID-19 PCR test is due to the development of newer tests that help save time and resources, not because the test is faulty
CDC spokesperson Jasmine Reed explained the reason for the withdrawal:
“Given the availability of commercial options for clinical diagnosis of SARS-CoV-2 infection, including multiplexed and high-throughput options, CDC intends to discontinue support for the CDC 2019 Novel Coronavirus (2019 nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2.
Although the CDC 2019 Novel Coronavirus (2019 nCoV) Real-Time RT-PCR Diagnostic Panel met an important unmet need when it was developed and deployed and has not demonstrated any performance issues, the demand for this test has declined with the emergence of other higher-throughput and multiplexed assays. CDC is encouraging public health laboratories (PHL) to adopt the CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay to enable continued surveillance for both influenza and SARS-CoV-2, which will save both time and resources for PHL.”
CDC spokesperson Jasmine Reed explained the reason for the withdrawal:
“Given the availability of commercial options for clinical diagnosis of SARS-CoV-2 infection, including multiplexed and high-throughput options, CDC intends to discontinue support for the CDC 2019 Novel Coronavirus (2019 nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2.
Although the CDC 2019 Novel Coronavirus (2019 nCoV) Real-Time RT-PCR Diagnostic Panel met an important unmet need when it was developed and deployed and has not demonstrated any performance issues, the demand for this test has declined with the emergence of other higher-throughput and multiplexed assays. CDC is encouraging public health laboratories (PHL) to adopt the CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay to enable continued surveillance for both influenza and SARS-CoV-2, which will save both time and resources for PHL.”
--------------------------------------------------------------------------------------------------------------------------
For a full picture of all the false information floating around on social media concerning PCR tests, you can read the full article here.
https://healthfeedback.org/claimreview/eua-withdrawal-for-cdc-covid-19-pcr-test-is-due-to-the-development-of-newer-tests-that-help-save-time-and-resources-not-because-the-test-is-faulty/
====================================================================
Welcome to DU!
Edit history
Please sign in to view edit histories.
19 replies
= new reply since forum marked as read
= new reply since forum marked as read
